Terug naar events

EpiVax- 3rd Annual Immunogenicity and Tolerance Seminar

EpiVax- 3rd Annual Immunogenicity and Tolerance Seminar
EVENT DETAILS
EVENT DETAILS
Date
09 November 2017
Location
Amsterdam, the Netherlands
Organizer
EpiVax

EpiVax is organizing their 3rd annual Immunogenicity and Tolerance Seminar on 9th of November, 2017.

Location: Hilton Apollolaan, Apollolaan 138, Amsterdam.

This ​meeting ​will ​focus ​on ​the ​determinants ​of ​immunogenicity ​– ​a ​key ​feature ​of ​effective ​vaccines ​and ​a ​key ​barrier ​to ​success ​in ​the ​clinic ​for ​protein ​therapeutics. ​Conversely, ​tolerance ​induction ​is ​a ​key ​feature ​of ​successful ​protein ​therapeutics, ​while ​suppressing ​immune ​responses ​to ​vaccines. ​The ​reduction ​of ​T ​cell ​epitopes ​and ​introduction ​of ​Treg ​epitopes ​(like ​Tregitopes) ​for ​protein ​therapeutics, ​and ​the ​reverse ​process ​for ​vaccines, ​will ​be ​discussed ​and ​illustrated ​in ​case ​studies. ​

Click Here to Register

Enjoy engaging presentations, case studies and discussions with speakers to include Dr. Annie ​De ​Groot, MD (EpiVax CEO), Marieke ​van ​Ham, PhD (Sanquin), Wim ​Jiskoot, ​PhD (Leiden ​University ​Medical ​Center), Vincent ​Lombardi, ​PhD (Stallergenes), Ab ​Osterhaus, ​PhD (University ​of ​Veterinary ​Medicine ​in ​Hannover, ​Germany), Bram ​Slütter, ​PhD (Leiden ​University) and Jagadeesh ​Bayry (Institut ​National ​de ​la ​Santé ​et ​de ​la ​Recherche ​Médicale ​(INSERM) ​Unité). Food, refreshments and cocktail hour to conclude. Register today to reserve your seat, and discover the positive reputation of our seminar:

“Good combination of talks about determinants of immunogenicity and tolerance. Very well hosted by Annie; made good connections between people in audience Good networking possibilities”

“Wide variety of topics related to immunogenicity, it forces us to go outside of our usual domain of expertise.”